Imatinib Completed Phase 2 Trials for CML / Imatinib Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01216085An Exploratory Study of High-dose Glivec in Patients With CML-CP Using Molecular Endpoints